Market Size of Asia-Pacific Bariatric Surgery Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 8.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Asia-Pacific Bariatric Surgery Market Analysis
The Asia-Pacific Bariatric Surgery Market is expected to register a CAGR of 8.5% during the forecast period. The key factors propelling the growth of the Asia pacific bariatric surgery market is the increase in the number of obese patients and the rising prevalence rate of type-2 diabetes and heart diseases.
Obesity is considered a metabolic dysfunction and is often associated with a wide range of chronic illnesses that cause significant increases in mortality. Obesity is found to be associated with substantial increases in premature mortality, impaired quality of life, and a substantial amount of healthcare costs.
As per Australian Bureau of Statistics' National Health Survey, in 2017-2018, about two thirds (67%) of Australian adults were overweight or obese (12.5 million people), up from 63.4% in 2014-2015. It is also indicated that almost one quarter (24.9%) of children who are aged 5-17 years were overweight or obese in 2017-2018 (17% overweight and 8.1% obese).
In addition, the emergence of new technologies in bariatric surgery and growing demand for minimally invasive surgical procedures that are acting as the key drivers for the market growth during the forecast period. Thus, bariatric surgery market in Asia-Pacific is expected to show significant growth over the forecast period.
Asia-Pacific Bariatric Surgery Industry Segmentation
As per the scope of the report, bariatric surgery is a medical procedure that aids the weight loss by either limiting the capacity of the stomach or the absorption of the calories. This is the most effective weight loss therapy available for patients with morbid obesity, and it involves either open or laparoscopic techniques. The Asia-Pacific Bariatric Surgery Market is segmented by the device (assisting devices, implantable devices and other devices).
| By Device | |||||||
| |||||||
| |||||||
| Other Devices |
| Geography | ||||||||
|
Asia-Pacific Bariatric Surgery Market Size Summary
The Asia-Pacific bariatric surgery market is poised for substantial growth, driven by the increasing prevalence of obesity and related chronic conditions such as type-2 diabetes and heart diseases. Obesity, recognized as a metabolic dysfunction, significantly elevates the risk of premature mortality and healthcare costs, impacting the quality of life. The demand for bariatric surgery is further bolstered by the rising number of obese individuals in the region, as evidenced by statistics from Australia and Japan, highlighting the urgent need for effective weight management solutions. The market is also experiencing a surge in interest due to advancements in surgical technologies and a growing preference for minimally invasive procedures, which are expected to enhance patient outcomes and streamline recovery.
In this competitive landscape, the stapling devices segment is anticipated to experience robust growth, attributed to its effectiveness in achieving consistent weight loss and reducing obesity-related health issues. The market is characterized by innovation, with major players like Medtronic PLC, Johnson and Johnson (Ethicon Inc), and Olympus Corporation leading the charge in developing non-invasive technologies that minimize hospital stays and infection risks. Additionally, smaller companies are strategically expanding their presence through acquisitions, aiming to diversify their product offerings and strengthen their market position. This dynamic environment underscores the potential for significant expansion in the Asia-Pacific bariatric surgery market over the forecast period.
Asia-Pacific Bariatric Surgery Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increase in Obesity Patients
-
1.2.2 Government Initiatives to Curb Obesity
-
1.2.3 Rising Prevalence of Type 2 Diabetes and Heart Diseases
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Surgery
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Device
-
2.1.1 Assisting Devices
-
2.1.1.1 Suturing Device
-
2.1.1.2 Closure Device
-
2.1.1.3 Stapling Device
-
2.1.1.4 Trocars
-
2.1.1.5 Other Assisting Devices
-
-
2.1.2 Implantable Devices
-
2.1.2.1 Gastric Bands
-
2.1.2.2 Electrical Stimulation Devices
-
2.1.2.3 Gastric Balloons
-
2.1.2.4 Gastric Emptying
-
-
2.1.3 Other Devices
-
-
2.2 Geography
-
2.2.1 Asia-Pacific
-
2.2.1.1 China
-
2.2.1.2 Japan
-
2.2.1.3 India
-
2.2.1.4 Australia
-
2.2.1.5 South Korea
-
2.2.1.6 Rest of Asia-Pacific
-
-
-
Asia-Pacific Bariatric Surgery Market Size FAQs
What is the current Asia-Pacific Bariatric Surgery Market size?
The Asia-Pacific Bariatric Surgery Market is projected to register a CAGR of 8.5% during the forecast period (2024-2029)
Who are the key players in Asia-Pacific Bariatric Surgery Market?
Medtronic PLC, Johnson and Johnson (Ethicon Inc), Olympus Corporation, Conmed Corporation and Apollo Endosurgery Inc are the major companies operating in the Asia-Pacific Bariatric Surgery Market.
